DEMODEX BLEPHARITIS

Clinical trials for DEMODEX BLEPHARITIS explained in plain language.

Never miss a new study

Get alerted when new DEMODEX BLEPHARITIS trials appear

Sign up with your email to follow new studies for DEMODEX BLEPHARITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New eye drop targets Mite-Related eyelid inflammation

Disease control Recruiting now

This study tests an experimental eye drop called GLK-321 for people with Demodex blepharitis, an eyelid condition caused by tiny mites. About 250 adults with signs of the condition will receive either the drug or a placebo for 6 weeks. The main goal is to see if the drops can cle…

Matched conditions: DEMODEX BLEPHARITIS

Phase: PHASE2 • Sponsor: Glaukos Corporation • Aim: Disease control

Last updated May 17, 2026 12:57 UTC

DEMODEX BLEPHARITIS

Get alerted when new DEMODEX BLEPHARITIS trials appear

New eye drop targets Mite-Related eyelid inflammation